Back to search

Belgium· BE-AMP-SAM664215-00

Eltrombopag Accord 25 mg

A eltrombopag product containing eltrombopag olamine, registered in Belgium by Accord Healthcare. The same ATC class is registered in 15 of our 19 countries.

ATC B02BX05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEltrombopag Accord 25 mgATCB02BX05REGISTER NO.BE-AMP-SAM664215-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Eltrombopag is registered in 15 of 19 countries.

Countries holding a registration under ATC B02BX05 (eltrombopag), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Eltrombopag · ATC B02BX05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eltrombopag costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Eltrombopag · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$38.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Eltrombopag Olamine
Manufacturer
Accord Healthcare
Country
Belgium (BE)
ATC code
B02BX05
ATC class
Eltrombopag
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7747264
  • be_apb
    4969101

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

175 interactions on record for eltrombopag.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eltrombopag · interactions on record

175 records

  • 20 severe
  • 153 moderate
  • 2 minor

Most severe, free to view

  • EluxadolineA07DA06severe
  • BerotralstatB06AC06severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eltrombopag in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eltrombopag products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Eltrombopag Ratiopharm
  • Bulgaria · Елтромбопаг Pht, Елтромбопаг Тева
  • Czechia · Eltrombopag Teva
  • Germany · Eltrombopag Ratiopharm, Eltrombopag Zentiva
  • Denmark · Eltrombopag Zentiva
  • Estonia · Eltrombopag Zentiva
  • Spain · Eltrombopag Teva, Eltrombopag Zentiva
  • France · Eltrombopag Arrow, Eltrombopag Sandoz
  • United Kingdom (Northern Ireland) · Eltrombopag Tilllomed, Eltrombopag Tillomed
  • Greece · Eltrombopag Ariti
  • Croatia · Rulemya 25 Mg Tablete, Rulemya 50 Mg Tablete
  • Italy · Eltrombopag Teva, Eltrombopag Zentiva
  • Lithuania · Eltrombopag Teva, Eltrombopag Zentiva
  • Luxembourg · Eltrombopag Ab
  • Netherlands · Eltrombopag Aurobindo, Eltrombopag Teva
  • Norway · Eltrombopag Teva, Eltrombopag Zentiva
  • Poland · Eltrombopag Zentiva
  • Portugal · Eltrombopag Generis, Eltrombopag Generis Phar
  • Sweden · Eltrombopag Teva Gmbh, Eltrombopag Zentiva
  • Slovakia · Eltrombopag Sandoz, Eltrombopag Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7ddf0ef-fe67-48ee-a33e-1721850f8a87
GET /v1/drugs/f7ddf0ef-fe67-48ee-a33e-1721850f8a87?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Eltrombopag Accord 25 mg",
  "name_fr": "Eltrombopag Accord 25 mg",
  "name_nl": "Eltrombopag Accord 25 mg",
  "amp_code": "SAM664215-00",
  "strengths": [
    "25.0000",
    "25.0000",
    "25.0000"
  ],
  "pack_count": 8,
  "substances": [
    "Eltrombopag Olamine",
    "Eltrombopag",
    "Isomalt",
    "Mannitol",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Eltrombopag",
  "authorisation_numbers": [
    "EU/1/24/1903/010",
    "EU/1/24/1903/005",
    "EU/1/24/1903/008",
    "EU/1/24/1903/006",
    "EU/1/24/1903/009",
    "EU/1/24/1903/007",
    "EU/1/24/1903/027",
    "EU/1/24/1903/028"
  ]
}

See everything about eltrombopag.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.